<SEC-DOCUMENT>0001387131-20-006559-index.html : 20200721
<SEC-HEADER>0001387131-20-006559.hdr.sgml : 20200721
<ACCEPTANCE-DATETIME>20200721080321
ACCESSION NUMBER:		0001387131-20-006559
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200721
DATE AS OF CHANGE:		20200721
GROUP MEMBERS:		AIGH CAPITAL MANAGEMENT, LLC
GROUP MEMBERS:		AIGH INVESTMENT PARTNERS, L.L.C.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91306
		FILM NUMBER:		201037690

	BUSINESS ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312
		BUSINESS PHONE:		610-727-3913

	MAIL ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HIRSCHMAN ORIN
		CENTRAL INDEX KEY:			0001131362

	FILING VALUES:
		FORM TYPE:		SC 13G

	MAIL ADDRESS:	
		STREET 1:		101 EAST 52ND ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>anvs-sc13g_071020.htm
<DESCRIPTION>SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
<TEXT>
Document 1 - file: anvs-sc13g_071020.htm

</DOCUMENT>
</SEC-DOCUMENT>